Onyx Biotec

{
  "main_header": {
    "sid": 10039457,
    "name": "Onyx Biotec",
    "stock_name": "Onyx Biotec",
    "full_name": "Onyx Biotec Ltd",
    "name_url": "stocks-analysis/onyx-biotec",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "35.50",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "35.50",
    "mcapval": "64.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "ONYX",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0WVU01018",
    "curr_date": "Feb 12",
    "curr_time": "",
    "bse_nse_vol": 54000,
    "exc_status": "Active",
    "traded_date": "Feb 12, 2026",
    "traded_date_str": "2026 02 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/onyx-biotec-10039457-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Onyx Biotec falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-onyx-biotec-fallingrising-3703909",
        "imagepath": "",
        "date": "2025-11-15 00:18:00",
        "description": "As of 14-Nov, Onyx Biotec Ltd is experiencing a decline in its stock price, currently at 38.50, which represents a decrease of 4.45 or 10.36%. The stock has underperformed its sector by 10.73% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 67.03% compared to the 5-day average. The stock has also shown poor performance over various periods, with a year-to-date decline of 35.29%, indicating ongoing challenges for the company.\n\nIn the broader market context, the Sensex has shown a positive return of 1.64% over the past week and 3.04% over the past month, contrasting sharply with Onyx Biotec's declines of 4.11% and 8.33% in the same periods. This suggests that while the overall market is performing well, Onyx Biotec is struggling significantly. The lack of avail..."
      }
    ],
    "total": 34,
    "sid": "10039457",
    "stock_news_url": "https://www.marketsmojo.com/news/onyx-biotec-10039457"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Onyx Biotec falling/rising?

2025-11-15 00:18:00

As of 14-Nov, Onyx Biotec Ltd is experiencing a decline in its stock price, currently at 38.50, which represents a decrease of 4.45 or 10.36%. The stock has underperformed its sector by 10.73% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 67.03% compared to the 5-day average. The stock has also shown poor performance over various periods, with a year-to-date decline of 35.29%, indicating ongoing challenges for the company. In the broader market context, the Sensex has shown a positive return of 1.64% over the past week and 3.04% over the past month, contrasting sharply with Onyx Biotec's declines of 4.11% and 8.33% in the same periods. This suggests that while the overall market is performing well, Onyx Biotec is struggling significantly. The lack of avail...

Read full news article

View All News